All
Results: 3781-3792 of 79340

Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation

IBM Advances Enterprise AI Software Development with Multi-Agent Capabilities and Specialized Modernization Workflows

Ruleguard Launches Continuous Assurance Platform to Help Financial Services Firms Move Beyond Periodic Compliance

FEV COLLABORATES WITH MICROSOFT ON EFFICIENT AI MODEL APPROACH FOR INCAR APPLICATIONS BUILT ON NVIDIA



